The price of GBIO is predicted to go up 7.42%, based on the high correlation periods with PODD. The similarity of these two price pattern on the periods is 98.17%.

GBIO

PODD

Up: 7.42%Similarity: 98.17%

GBIO Revenue Forecast

GBIO EPS Forecast

GBIO FAQs

What is bull’s view on GBIO?

GBIO stock has bullish potential due to its insider buying activity, with Anthony G. Quinn purchasing 210,791 shares at $0.96, signaling confidence in the company. The stock is currently trading higher, reflecting positive sentiment and potential upside. Additionally, its innovative ctLNP technology and strong cash position of $199.8M provide a solid foundation for long-term growth.

What is bear's view on GBIO?

GBIO stock is bearish due to its weak financial performance and uncertain future. The stock closed at $0.7761 on January 31, 2025, down 4.52% in regular trading, reflecting market skepticism about its growth potential. Despite insider buying and advancements in siRNA technology, the company’s cash burn and delayed clinical milestones (IND submission in 2026) weigh heavily on investor sentiment.